17-82752221-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005993.5(TBCD):c.28G>T(p.Gly10Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 1,524,528 control chromosomes in the GnomAD database, including 14,468 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_005993.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBCD | NM_005993.5 | c.28G>T | p.Gly10Cys | missense_variant | 1/39 | ENST00000355528.9 | NP_005984.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBCD | ENST00000355528.9 | c.28G>T | p.Gly10Cys | missense_variant | 1/39 | 1 | NM_005993.5 | ENSP00000347719 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0968 AC: 14724AN: 152112Hom.: 997 Cov.: 33
GnomAD3 exomes AF: 0.134 AC: 15535AN: 115536Hom.: 1473 AF XY: 0.149 AC XY: 9547AN XY: 63984
GnomAD4 exome AF: 0.133 AC: 182038AN: 1372302Hom.: 13471 Cov.: 31 AF XY: 0.138 AC XY: 93207AN XY: 677094
GnomAD4 genome AF: 0.0968 AC: 14733AN: 152226Hom.: 997 Cov.: 33 AF XY: 0.0990 AC XY: 7370AN XY: 74424
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at